These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 4474726)

  • 1. Probit analysis of cytotoxicity data.
    Papermaster BW; Pincus JH; Lincoln P; Reisfeld RA
    Transplantation; 1974 Dec; 18(6):541-4. PubMed ID: 4474726
    [No Abstract]   [Full Text] [Related]  

  • 2. A microassay for the detection of murine H-2 antigens.
    Pincus JH; Gordon RO
    Transplantation; 1971 Dec; 12(6):509-13. PubMed ID: 4941054
    [No Abstract]   [Full Text] [Related]  

  • 3. [The role of complement in the microlymphocytoxicity test. Human and guinea pig complement].
    Májský A
    Cas Lek Cesk; 1980 Nov; 119(45):1210-5. PubMed ID: 7438183
    [No Abstract]   [Full Text] [Related]  

  • 4. Cytotoxic antibodies and lymphocytes induced by orthotopic tooth bud allografts in mice.
    Riviere GR
    J Immunol; 1974 Feb; 112(2):776-82. PubMed ID: 4205208
    [No Abstract]   [Full Text] [Related]  

  • 5. Physical properties of mouse spleen cells involved in the mixed leukocyte reaction and graft-vs-host disease.
    el-Arini MO; Osoba D
    J Immunol; 1973 Jun; 110(6):1476-84. PubMed ID: 4145892
    [No Abstract]   [Full Text] [Related]  

  • 6. Plaque assay for the detection of alloantibody-producing cells in mice.
    Wong AK; Sabbadini E
    J Immunol; 1974 Jun; 112(6):2251-9. PubMed ID: 4596699
    [No Abstract]   [Full Text] [Related]  

  • 7. Early evaluation of mixed leukocyte interactions in mice and guinea pigs using measurements of protein synthesis.
    Schechter B; Rosenberg SA; Levy R; Ficker S; Terry WD
    Cell Immunol; 1973 Feb; 6(2):261-72. PubMed ID: 4266457
    [No Abstract]   [Full Text] [Related]  

  • 8. An effector-cell independent step in target cell lysis by sensitized mouse lymphocytes.
    Martz E; Benacerraf B
    J Immunol; 1973 Nov; 111(5):1538-45. PubMed ID: 4200780
    [No Abstract]   [Full Text] [Related]  

  • 9. Latent homology of murine lymphoid antigens revealed through the complement mediated absorption of xenogeneic antiserum.
    Drake WP; Roberts GC; Mardiney MR
    Biomedicine; 1976 Nov; 24(5):329-33. PubMed ID: 63296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cytolytic activity of human lymphocytes. I. Cytolytic activity towards PPD-coated target cells in tuberculin positive and negative individuals.
    Rehn TG; Henney CS
    Johns Hopkins Med J; 1972 Oct; 131(4):261-70. PubMed ID: 5081728
    [No Abstract]   [Full Text] [Related]  

  • 11. Stimulus-response in the mixed lymphocyte reaction.
    Harrison MR; Paul WE
    J Exp Med; 1973 Dec; 138(6):1602-7. PubMed ID: 4543459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The serologic behaviour of neuraminidase-treated lymphoid cells. Alloantigenicity and complement sensitivity.
    Ray PK; Gewurz H; Simmons RL
    Clin Exp Immunol; 1972 Jul; 11(3):441-60. PubMed ID: 5042921
    [No Abstract]   [Full Text] [Related]  

  • 13. Cell-mediated and humoral immunity studies of murine and hamster sarcoma virus-induced producer and non-producer tumors in syngeneic animals.
    McCoy JL; Ting RC; McCoy NT; Reisher JI; Chan SP; Law LW
    Int J Cancer; 1974 May; 13(5):731-41. PubMed ID: 4367343
    [No Abstract]   [Full Text] [Related]  

  • 14. Antigenic differences between spleen-seeking and lymph node-seeking thymus cells.
    Schlesinger M; Shlomai-Korzash Z; Israèl E
    Eur J Immunol; 1973 Jun; 3(6):335-9. PubMed ID: 4543317
    [No Abstract]   [Full Text] [Related]  

  • 15. Antibody-dependent lymphoid cell-mediated cytotoxicity: role of complement.
    Van Boxel JA; Paul WE; Green I; Frank MM
    J Immunol; 1974 Jan; 112(1):398-403. PubMed ID: 4812178
    [No Abstract]   [Full Text] [Related]  

  • 16. Immune cytolysis of human tumor cells mediated by xenogeneic "immune" ribonucleic acid: implications for immunotherapy.
    Veltman LL; Kern DH; Pilch YH
    Am J Obstet Gynecol; 1974 Aug; 119(7):959-65. PubMed ID: 4135321
    [No Abstract]   [Full Text] [Related]  

  • 17. Generation of non-complement-fixing, blocking factors by lysosomal extract treatment of cytotoxic anti-tumor antibodies.
    Dauphinee MJ; Talal N; Witz IP
    J Immunol; 1974 Sep; 113(3):948-53. PubMed ID: 4413555
    [No Abstract]   [Full Text] [Related]  

  • 18. Interferonogenicity of antigens and "early" cytotoxicity of lymphocytes.
    Svet-Moldavsky GJ; Nemirovskaya BM; Osipova TV; Slavina EG; Zinzar SN; Karmanova NV; Morozova LF
    Folia Biol (Praha); 1974; 20(4):225-30. PubMed ID: 4413935
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of neuraminidase on serological properties of murine lymphoid cells.
    Schlesinger M; Amos BD
    Transplant Proc; 1971 Mar; 3(1):895-7. PubMed ID: 4106346
    [No Abstract]   [Full Text] [Related]  

  • 20. Role of macrophages in tumour immunity. II. Involvement of a macrophage cytophilic factor during syngeneic tumour growth inhibition.
    Evans R; Alexander P
    Immunology; 1972 Oct; 23(4):627-36. PubMed ID: 4563478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.